Accelerate biotechnology

Batavia Bioservices will participate in a SME partnership program called “Off-the-shelf-antigen-loaded dendritic cell vaccines”

Leiden, November 26th, 2012 Batavia Bioservices herewith announces that it will participate in a SME partnership program titled “Off-the-shelf-antigen-loaded dendritic cell vaccines” Batavia Bioservices will be involved in the development of assays to determine potency and stability of novel cancer vaccines. The consortium that was awarded this TI Pharma SME partnership call 2012 consists of…


Batavia Bioservices launches laboratory infrastructure in Greater Boston area

Leiden, April 3rd, 2012 Batavia Bioservices launches laboratory infrastructure in Greater Boston area. As of February 2012 Batavia Bioservices deploys 5.300 square feet of laboratories at 300 TradeCenter, Suite 6650, Woburn, MA 01801. The dedicated BSL-2 laboratories have been fully equipped to offer to our customers high quality DNA preparative services, transient protein production, stable…


Batavia Bioservices has been awarded a prestigious European grant

Leiden, January 2nd, 2012 Batavia Bioservices is proud to announce that it has been awarded a prestigious European grant (FP7-program) UNDER THE MARIE CURIE INITIAL TRAINING NETWORK (ITN). The program, which is executed by a consortium of world class industrial and academic partners and COORDINATED by Professor A. Baker (University of Glasgow, UK) focuses on…


Batavia Bioservice will participate in a grant from the Bill and Melinda Gates Foundation

Leiden, January 2nd, 2012 Batavia Bioservices is proud to announce that the company will participate in a prestigious grant from the Bill and Melinda Gates Foundation awarded to Beth Israel Deaconess Medical Center (BIDMC), a major teaching hospital of Harvard Medical School. This grant will fund the development and clinical evaluation of a novel candidate…


Batavia Bioservices BV and Xendo BV announce Business collaboration

Leiden, August 25th, 2011 Today Batavia Bioservices BV and Xendo BV announce that they have initiated a strategic business collaboration. As a consequence, all Bioprocess activities of Xendo Manufacturing BV have been transferred to Batavia Bioservices BV. This provides Batavia Bioservices BV access to unique simulated moving bed (SMB) purification technology as well as infrastructure,…


Expanding our market & sales activities

Leiden, April 19th, 2011 Batavia Bioservices is pleased to announce that it has successfully engaged Dr. David Hone and Dr. Tineke Meijers (North America) and Dr Michael Murray (United Kingdom) to strengthen the marketing and sales activities of the company. Dr. David Hone is a biotech professional with more than 25 years of experience in…


Batavia Bioservices to launch US presence

Leiden, January 10th, 2011 Batavia Bioservices B.V. is pleased to announce that it has launched a wholly owned US subsidiary, Batavia Bioservices Inc., with offices in the Rockville innovation Center, 155, Gibbs Street, Suite 521, Rockville, MD20850. The location for the office in Montgomery County was chosen since this region is home to more than…


Batavia Bioservices expands operations in the Netherlands

Leiden, January 10th, 2011 In order to meet growing customer demand, the company has decided to significantly expand its operations in the Gaubius Building of the Leiden Bioscience Park, The Netherlands. The additional offices and laboratories will support an expansion of our services in upstream process development, downstream process development, assay development, and molecular virology….